| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/01/2005 | EP1534681A1 Substituted quinoline ccr5 receptor antagonists |
| 06/01/2005 | EP1534677A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 06/01/2005 | EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 06/01/2005 | EP1534675A1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo[3.1.0]hexane derivatives as muscarinic receptor antagonists |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1534667A1 Muscarinic agonists |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534512A1 Coated particles, methods of making and using |
| 06/01/2005 | EP1534508A1 Embossable and writable multilaminate backing construction |
| 06/01/2005 | EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 06/01/2005 | EP1534389A2 Pyrazolopyrimidines as kinase inhibitors |
| 06/01/2005 | EP1534321A1 Methods of use of compounds with preptin function |
| 06/01/2005 | EP1534310A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 06/01/2005 | EP1534304A1 An analgesic agent for newborn or fetal subjects |
| 06/01/2005 | EP1534300A2 3, 10, and 12a substituted tetracycline compounds |
| 06/01/2005 | EP1534299A2 Methods for treating psychosis associated with interferon-alpha therapy |
| 06/01/2005 | EP1534291A2 2-(phenoxymethyl)- and 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534285A2 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534268A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1534254A2 Method of promoting smoking cessation |
| 06/01/2005 | EP1534251A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534243A1 Treating alzheimers using delipidated protein particles |
| 06/01/2005 | EP1534241A1 Transdermal aerosol compositions |
| 06/01/2005 | EP1534238A1 Formulations and dosage forms for controlled delivery of topiramate |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1347760B1 Nmda receptor agonist pharmaceutical compositions |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1335730B1 Use of pde5 inhibitors for the treatment of premature ejaculation |
| 06/01/2005 | EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1171160B1 Method and means for treating post-polio syndrome |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 06/01/2005 | EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0981353B1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | EP0937715B1 Tetrahydrobenzindole compounds |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound |
| 06/01/2005 | CN1622804A Orodispersible pharmaceutical composition of agomelatine |
| 06/01/2005 | CN1621094A Gene transfer for regulating smooth muscle tone |
| 06/01/2005 | CN1621080A Medicine for abstaining from drug addiction and its preparation |
| 06/01/2005 | CN1621078A Traditional Chinese medicine composition for treating intelligence impairment and dementia and preparation method thereof |
| 06/01/2005 | CN1621060A Sobering up product and its preparation |
| 06/01/2005 | CN1621059A Chinese traditional medicine composition for refreshing and improving vision acuity |
| 06/01/2005 | CN1621056A Mind tranquilizing capsule |
| 06/01/2005 | CN1621055A Pure Chinese traditional medicine for treating epilepsia |
| 06/01/2005 | CN1621041A Pharmaceutical composition with pain easing function |
| 06/01/2005 | CN1621039A Targeted preparation via nose to brain of Huperzine and its derivant or its salt |
| 06/01/2005 | CN1204139C Remedies for neuropathic pain and model animals of neuropathic pain |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1203896C Low substituted ethylene-lactic cellulose and solid preparation |
| 06/01/2005 | CN1203867C Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia |
| 06/01/2005 | CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 06/01/2005 | CN1203860C Application of Na-ion channel blocker and aspirin in preparing antalgic medicine for mammal |
| 06/01/2005 | CN1203858C Pharmaceutically active morpholinol |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 06/01/2005 | CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical |
| 05/31/2005 | US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye |
| 05/31/2005 | US6900354 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
| 05/31/2005 | US6900353 Cyclopentyl sulfonamide derivatives |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900333 Dissolving in aqueous solution containing alcohols; distillation; purification |
| 05/31/2005 | US6900329 MCH antagonists and their use in the treatment of obesity |
| 05/31/2005 | US6900327 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/31/2005 | US6900240 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. |
| 05/31/2005 | US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 05/31/2005 | US6900216 Psychological disorders; antidepressants; brain diosrders; anticonvulsants |
| 05/31/2005 | US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 05/31/2005 | US6900212 Anxiolytic agents; psychological disorders; sexual disorders; eating disorders |
| 05/31/2005 | US6900211 CCR5 antagonists useful for treating aids |
| 05/31/2005 | US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 05/31/2005 | US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/31/2005 | US6900054 Propagating preferential oligodendrocytes and/or astrocytes using embryonic neural cell adhesion molecule (E-NCAM) differentiated stem cells for treating neurological or neurodegenerative disease |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |